Ken Griffin Taro Pharmaceutical Industries LTD Transaction History

Citadel Advisors LLC

$559 Billion
Q4 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$40.97 - $43.33 $466,771 - $493,658	11,393 Added 75.57%	26,469 $1.12 Million
Q4 2023 Feb 14, 2024	SELL	$32.77 - $42.31 $248,724 - $321,132	-7,590 Reduced 33.49%	15,076 $629,000
Q3 2023 Nov 14, 2023	BUY	$35.46 - $40.13 $803,736 - $909,586	22,666 New	22,666 $854,000
Q3 2022 Nov 14, 2022	SELL	$28.74 - $39.9 $190,316 - $264,217	-6,622 Reduced 36.69%	11,425 $343,000
Q2 2022 Aug 15, 2022	BUY	$35.0 - $43.59 $156,030 - $194,324	4,458 Added 32.81%	18,047 $653,000
Q1 2022 May 16, 2022	SELL	$43.12 - $50.3 $201,197 - $234,699	-4,666 Reduced 25.56%	13,589 $587,000
Q4 2021 Feb 14, 2022	BUY	$47.6 - $65.0 $583,100 - $796,250	12,250 Added 204.0%	18,255 $0
Q3 2021 Nov 15, 2021	BUY	$62.34 - $73.38 $374,351 - $440,646	6,005 New	6,005 $382,000
Q1 2021 May 17, 2021	SELL	$70.48 - $79.95 $1.58 Million - $1.79 Million	-22,378 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$54.4 - $73.42 $1.5 Million - $2.02 Million	-27,520 Reduced 55.15%	22,378 $1.64 Million
Q3 2020 Nov 16, 2020	SELL	$54.41 - $68.2 $2.11 Million - $2.64 Million	-38,761 Reduced 43.72%	49,898 $2.74 Million
Q2 2020 Aug 14, 2020	SELL	$61.66 - $70.16 $6.43 Million - $7.31 Million	-104,204 Reduced 54.03%	88,659 $5.9 Million
Q1 2020 May 15, 2020	BUY	$59.35 - $88.73 $8.01 Million - $12 Million	135,018 Added 233.41%	192,863 $11.8 Million
Q4 2019 Feb 14, 2020	SELL	$74.18 - $97.92 $1.14 Million - $1.5 Million	-15,321 Reduced 20.94%	57,845 $5.09 Million
Q3 2019 Nov 14, 2019	BUY	$75.36 - $86.57 $2.09 Million - $2.4 Million	27,733 Added 61.04%	73,166 $0
Q2 2019 Aug 14, 2019	BUY	$83.92 - $108.88 $332,155 - $430,947	3,958 Added 9.54%	45,433 $3.88 Million
Q1 2019 May 15, 2019	SELL	$85.97 - $108.09 $3.49 Million - $4.38 Million	-40,541 Reduced 49.43%	41,475 $0
Q4 2018 Feb 14, 2019	BUY	$78.25 - $107.92 $2.9 Million - $4 Million	37,088 Added 82.55%	82,016 $0
Q3 2018 Nov 13, 2018	BUY	$97.82 - $116.09 $3.81 Million - $4.52 Million	38,960 Added 652.82%	44,928 $0
Q1 2018 May 11, 2018	BUY	$95.91 - $107.26 $572,390 - $640,127	5,968 New	5,968 $589,000

Others Institutions Holding TARO

# of Institutions

Shares Held

16.8K

Call Options Held

Put Options Held

View Full List

About TARO PHARMACEUTICAL INDUSTRIES LTD

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

More about TARO

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account